Cargando…

Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease

BACKGROUND: Fingolimod is the first oral immunomodulatory therapy approved for highly active relapsing remitting multiple sclerosis. Based on the distribution pattern of fingolimod interacting sphingosine-1-phosphat receptors in organism including immune system and cardiovascular system clinical mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Katja, Schrötter, Hagen, Halank, Michael, Ziemssen, Tjalf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055797/ https://www.ncbi.nlm.nih.gov/pubmed/24906818 http://dx.doi.org/10.1186/1471-2377-14-126

Ejemplares similares

Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients
por: Lerche, Marianne, et al.
Publicado: (2019)

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis
por: Li, Kai, et al.
Publicado: (2017)

Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration
por: Sehr, Tony, et al.
Publicado: (2020)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients
por: Kaufmann, Maxi, et al.
Publicado: (2018)

Heart Failure as the Initial Presentation of Anomalous Left Coronary Artery From the Pulmonary Artery
por: Rao, Suman, et al.
Publicado: (2022)

Practical management of riociguat in patients with pulmonary arterial hypertension
por: Halank, Michael, et al.
Publicado: (2019)

No Impact of Long-Term Fingolimod Treatment on Fecal Secretory Immunoglobulin A Levels in Patients With Multiple Sclerosis
por: Inojosa, Hernan, et al.
Publicado: (2020)

Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation
por: Thomas, Katja, et al.
Publicado: (2017)

Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

Right coronary artery diastolic perfusion pressure on outcome of patients with left heart failure and pulmonary hypertension
por: Hamud, Amir, et al.
Publicado: (2021)

Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Harzheim, Dominik, et al.
Publicado: (2013)

A Cardiac Arrest Case due to Left Coronary Artery Compression in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
por: Chida-Nagai, Ayako, et al.
Publicado: (2022)

Pulmonary artery hypertension following coronary artery bypass grafting: a case report
por: Robinson, Renana, et al.
Publicado: (2018)

Chronic thromboembolic pulmonary hypertension mimicking coronary artery disease
por: Correale, Michele, et al.
Publicado: (2020)

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

Anomalous Left Coronary Artery From The Pulmonary Artery (ALCAPA) as a Cause of Heart Failure
por: Sadoma, Daniel, et al.
Publicado: (2019)

Heart-lung transplantation for idiopathic pulmonary arterial hypertension and giant pulmonary artery aneurysm – case report
por: Eadington, T., et al.
Publicado: (2020)

Monotherapy in patients with pulmonary arterial hypertension at four German PH centres
por: Stubbe, Beate, et al.
Publicado: (2021)

Left Main Coronary Artery Compression in Pulmonary Arterial Hypertension: Percutaneous Treatment to Improve Symptoms
por: Edginton, Stefan, et al.
Publicado: (2020)

Renal replacement therapy as a therapeutic option for right heart failure in severe pulmonary arterial hypertension
por: Shimbo, Mai, et al.
Publicado: (2022)

Pulmonary hypertension complicating unilateral absence of pulmonary artery and coronary‐pulmonary artery fistula: Report of a case and review of the literature
por: Lin, Chen‐Chieh, et al.
Publicado: (2022)

Coronary Artery and Pulmonary Artery Fistula: Rare Congenital Coronary Artery Fistula
por: Sherif, Khaled, et al.
Publicado: (2020)

Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosis
por: Akgün, Katja, et al.
Publicado: (2018)

Total Occlusion of Left Main Coronary Artery by Dilated Main Pulmonary Artery in a Patient with Severe Pulmonary Hypertension
por: Lee, Juyong, et al.
Publicado: (2001)

Heart Failure in Pulmonary Arterial Hypertension Is Just a WNK1 Away
por: Ha, Chae-Myeong, et al.
Publicado: (2021)

Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis
por: Hamberger, Florian, et al.
Publicado: (2022)

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Pulmonary hypertension and pulmonary artery dissection
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2013)

Coronary flow reserve correlates with right ventricular dysfunction and predicts right heart failure in patients with pulmonary arterial hypertension
por: Skrok, Jan, et al.
Publicado: (2011)

Pulmonary function differences in patients with chronic right heart failure secondary to pulmonary arterial hypertension and chronic left heart failure
por: Liu, Wei-Hua, et al.
Publicado: (2014)

Significant stenoses of twin circumflex arteries accompanied by heart failure: a rare coronary artery anomaly
por: Cicek, Darvan, et al.
Publicado: (2011)

Pulmonary artery denervation improves hemodynamics and cardiac function in pulmonary hypertension secondary to heart failure
por: Zhang, Hang, et al.
Publicado: (2018)

Left main coronary artery compression by a dilated main pulmonary artery and left coronary sinus of Valsalva aneurysm in a patient with heritable pulmonary arterial hypertension and FLNA mutation
por: Hirashiki, Akihiro, et al.
Publicado: (2017)

Pulmonary arterial hypertension and pregnancy
por: Terek, Demet, et al.
Publicado: (2013)

Left main coronary artery compression by a large pulmonary artery aneurysm in the absence of pulmonary hypertension: a case report
por: Miranda-Barrio, Berta, et al.
Publicado: (2018)

Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany
por: Ziemssen, Tjalf, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kt2n41c95q08iljb0aus5kkf8g